Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane 4 L6 family member 4 (TM4SF4) is a member of the transmembrane 4 superfamily (TM4SF), with four membrane-spanning domains and two extracellular loops[1]. It is structurally similar to tetraspanins and primarily expressed in epithelial intestinal cells and hepatocytes, where it plays roles in cellular differentiation, migration, and interaction with other membrane proteins[1]. TM4SF4 is implicated in signal transduction pathways that regulate cell growth, adhesion, motility, and tissue differentiation[1]. Elevated expression of TM4SF4 has been linked to various cancers (including colorectal, lung, and liver), where it influences tumor progression, metastasis, and resistance to chemotherapeutic treatments[1]. It is under investigation as both a prognostic and diagnostic biomarker, and its functional importance in cancer biology makes it a potential therapeutic target[1]. There are currently no clinically validated drugs targeting TM4SF4, and its detailed mechanisms of action as a drug target remain to be characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane 4 L6 family member 4 (TM4SF4).